Irpagratinib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Irpagratinib, covering 2026-03-18 to 2026-03-18. Get the full timeline:
Most recent: Clinical Trial Update: A Prospective Study to Evaluate the Safety and Efficacy of the Combination Therapy of Irpagratinib, Atezolizumab, and Bevacizumab in Patients With Hepatocellular Carcinoma [Phase 2]